Characterization of a hemagglutinin-specific inhibitor of influenza A virus

Virology

Volumn 226, Issue 1, 1996, Pages 66-76

  Luo, Guangxiang ^a   Colonno, Richard ^a   Krystal, Mark ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BMY 27709; HEMAGGLUTININ; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 0030560967     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0628     Document Type: Article

References (56)

1. Air, G., and Laver, W. G. (1989). The neuraminidase of influenza virus. Proteins 6, 341-356.
2. Barrett, T., and Inglis, S. C. (1985). Growth, purification and titration on influenza viruses. In "Virology: A Practical Approach" (B. W. J. Mahy, Ed.), pp. 119-150. IRL Press, Oxford, UK.
3. Bodian, D. L., Yamasaki, R. B., Stearns, R. L., Steven, J. F., White, J. M., and Kuntz, I. D. (1993). Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32, 2967-2978.
4. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43.
5. Carr, C. M., and. Kim, P. S. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832.
6. Carr, C. M., and Kim, P. S. (1994). Flu Virus Invasion: Halfway There. Science 266, 234-236.
7. Centers for Disease Control. (1992). Outbreak of Influenza A in a nursing home - New York, December 1991-January 1992. Morbid. Mortal. Weekly Rep. 41, 129-131.
8. Cianci, C., Chung, T. D. Y., Meanwell, N., Putz, H., Hagen, M., Colonno, R. J., and Krystal, M. (1996). Identification of N-hydroxamic acid and n-hydroxy-imide compounds that inhibit the influenza virus polymerase. Antiviral Agents Chemother., in press.
9. Colman, P. M. (1989). Neuraminidase, enzyme and antigen. In "The Influenza Viruses" (R. M. Krug, Ed.), pp. 175-218. Plenum Press, NY.
10. Colman, P. M. (1994). Influenza virus neuraminidase: Structure, Antibodies, and Inhibitors. Protein Sci. 3, 1687-1696.
11. Enami, M., Luytjes, W., Krystal, M., and Palese, P. (1990). Introduction of site specific mutations into the genome of influenza virus. Proc. Nat. Acad. Sci. USA 87, 3802-3805.
12. Enami, M., and Palese, P. (1991). High-efficiency formation of influenza virus transfectants. J. Virol. 65, 2711-2713.
13. Hay., A. J. (1992). The action of amantadine against influenza A viruses; inhibition of the M2 ion channel protein. Semin. Virol. 3, 21-30.
14. Hayden, F. G., Belshe, R. B., Glover, R. D., Hay, A. J., Oakes, M. G., and Soo, W. (1989). Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N. Engl. J. Med. 321 (25), 1696-1702.
15. Hayden, F., Treanor, J. J., Betts, R. F., Lobo, M., Esinhart, J., and Hussey, E. (1996). Safety and efficacy of the neuraminidase inhibitor GG-167 in experimental human influenza. J. Am. Med. Assoc. 275, 295-299.
16. Hastings, J. C., Selnick, H., Wolanski, B., and Tomassini, J. E. (1996). Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob. Agents Chemother. 40, 1304-1307.
17. Helenius, A. (1992). Unpacking the incoming influenza virus. Cell 69, 577-578.
18. Hensens, O. D., Goetz, M. A., Liesch, J. M., Zink, D. L., Raghoobar, S. L., Helms, G. L., and Singh, S. B. (1995). Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus. Tetrahedron Lett. 36, 2005-2008.
19. Hiti, A. L., Davis, A. R., and Nayak, D. R. (1981). Complete sequence analysis shows that the hemagglutinins of the H1 and H2 subtypes of human influenza virus are closely related. Virology 111, 113-124.
20. Huang, T.-S.,. Palese, P., and Krystal, M. (1990). Determination of influenza virus proteins required for genome replication. J. Virol. 64, 5669-5673.
21. Kemble, G. W., Danieli, T., and White, J. M. (1994). Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76, 382-391.
22. Klenk, H. D., and Rott, R. (1988). The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34, 247-281.
23. Krug, R. M., Alonso-Caplen, F. V., Julkunen, I., and Katze, M. G. (1989). Expression and replication of the influenza virus genome. In "The Influenza Viruses" (R. M. Krug, Ed.), pp. 89-152. Plenum Press, NY.
24. Kurtz, S., Luo, G., Hahnenberger, K. M., Brooks, C., Gecha, O., Ingalls, K., Numata, K., and Krystal, M. (1995). Growth impairment resulting from expression of influenza virus M2 protein in yeast: identification of an inhibitor of M2. Antimicrob. Agents Chemother. 39, 2204-2209.
25. Li, S.-Q., Schulman, J. L., Moran, T., Bona, C., and Palese, P. (1992). Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J. Virol. 66, 399-404.
26. Lui, K.-J., and Kendal, A. P. (1987). Impact of Influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health 77, 712-716.
27. Luo, G.-X., Bergmann, M., Garcia-Sastre, A., and Palese, P. (1992). Mechanism of attenuation of a chimeric influenza A/B transfectant virus. J. Virol. 66, 4679-4685.
28. Luo, G.-X., and Palese, P. (1992). Genetic analysis of influenza virus. Curr. Opinion Genet. Dev. 2, 77-81.
29. Luytjes, W., Krystal, M., Enami, M., Parvin, J. D., and Palese, P. (1989). Amplification, expression and packaging of a foreign gene by influenza virus. Cell 59, 1107-1113.
30. Murphy, B. R., and Webster, R. G. (1990). Orthomyxoviruses. In "Virology" (B. N. Fields and D. M. Knipe, Eds.), 2nd ed., pp. 1091-1152. Raven Press, New York.
31. Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y., and Nakajima, K. (1991). Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182, 475-485.
32. Pak, C. C., Krumbiegel, M., and Blumenthal, R. (1994). Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusion. J. Gen. Virol. 75, 395-399.
33. Palese, P. (1977). The genes of influenza virus. Cell 10, 1-10.
34. Palese, P., Tobita, K., Ueda, M., and Compans, R. W. (1974). Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397-410.
35. Pinto, L. H., Holsinger, L. J., and Lamb, R. A. (1992). Influenza virus M2 protein has ion channel activity. Cell 69, 517-528.
36. Pinto, L. H., and Lamb, R. A. (1995). Understanding the mechanism of action of the anti-influenza virus drug amantadine. Trends Microbiol. 3(7), 271.
37. Roth, M. G., Gething, M.-J., and Sambrook, J. (1989). Membrane insertion and intracellular transport of influenza virus glycoproteins. In "The Influenza Viruses" (R. M. Krug, Ed.) pp. 219-267, Plenum Press, NY.
38. Ryan, D. M., Ticehurst, J., and Dempsey, M. H. (1995). GG-167 (4-Guanidino-2,4-dideoxy-2,3-dehydro-N-aceylneuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob. Agents Chemother. 39, 2583-2584.
39. Ryan, D. M., Ticehurst, J., Dempsey, M. H., and Penn, C. R. (1994). Inhibition of influenza virus replication in mice by GG-167 (4-Guanidino-2,4-dideoxy-2,3-dehydro-N-aceylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase). Antimicrob. Agents Chemother. 38, 2270-2275.
40. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Nat. Acad. Sci. USA 74, 5463-5467.
41. Schulman, J. L., and Palese, P. (1976). Selection and identification of influenza virus recombinants of defined genetic composition. J. Virol. 20, 248-254.
42. Sladowski, D., Steer, S. J., Clothier, R. H., and Balls, M. (1993). An improved MTT assay. J. Immunol. Methods 157, 203-207.
43. Stegmann, T., and Helenius, A. (1993). Influenza virus fusion: from models toward a mechanism. In "Viral Fusion Mechanisms" (J. Bentz, Ed.), pp. 89-111. CRC Press, Boca Raton, FL.
44. Steinhauer, D. A., Sauter, N. K., Skehel, J. J., and Wiley, D. C. (1992). Receptor binding and cell entry by influenza viruses. Semin. Virol. 3, 91-100.
45. Tatulian, S. A., Hinterdorfer, P., Baber, G., and Tamm, L. K. (1995). Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy. EMBO J. 14, 5514-5523.
46. Tomassini, J. E., Davies, M. E., Hastings, J. C., Lingham, R., Mojena, M., Raghoobar, S. L., Singh, S. B., Tkacz, J. S., and Goetz, M. A. (1996). A novel antiviral agent which inhibits the endonuclease of influenza virus. Antimicrob. Agents Chemother. 40, 1189-1193.
47. 7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob. Agents Chemother. 38, 2827-2837.
48. Tu, Q., Pinto, L. H., Luo, G., Shaughnessy, M. A., Mullaney, D., Kurtz, S., Krystal, M., and Lamb, R. A. (1996). Characterization of inhibition of M2 ion channel activity by BL-1743, a novel inhibitor of influenza A virus. J. Virol. 70, 4246-4252.
49. von Itzstein, M., Wu, W.-Y, Kok, G. B., Pegg, M. S., Dyason, J. C., Jn, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., Colman, P. W., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hotham, V. J., Cameron, J. M., and Penn, C. R. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
50. Webster, R. G., Bean, W. J., German, O. T., Chambers, T. M., and Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol. Rev. 56, 152-179.
51. Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J., and Wiley, D. C. (1988). Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 332, 426-431.
52. White, J. M. (1990). Viral and Cellular membrane fusion proteins. Annu. Rev. Physiol. 52, 675-697.
53. White, J. M. (1992). Membrane fusion. Science 258, 917-924.
54. Wiley, D. C., and Skehel, J. J. (1987). The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56, 365-394.
55. Wilson, I. A., Skehel, J. J., and Wiley, D. C. (1981). Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3Å resolution. Nature 289, 366-373.
56. Woods, J. M., Bethell, R. C., Coates, J. A. V., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D. M., Ticehurst, J., Tilling, J., Walcott, S. M., and Penn, C. R. (1993). 4-Guanidino-2,4-Dideoxy-2,3-Dehydro-N-Acetyl-neuraminic Acid is a highly effective inhibitor both of sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37, 1473-1479.